DD223447A5 - Verfahren zur herstellung neuer acylierter hydrazinverbindungen - Google Patents

Verfahren zur herstellung neuer acylierter hydrazinverbindungen Download PDF

Info

Publication number
DD223447A5
DD223447A5 DD84266047A DD26604784A DD223447A5 DD 223447 A5 DD223447 A5 DD 223447A5 DD 84266047 A DD84266047 A DD 84266047A DD 26604784 A DD26604784 A DD 26604784A DD 223447 A5 DD223447 A5 DD 223447A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
acid
lower alkyl
group
Prior art date
Application number
DD84266047A
Other languages
German (de)
English (en)
Inventor
Walter Fuhrer
Karl G Hofbauer
Ernst Habicht
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD223447A5 publication Critical patent/DD223447A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77—Hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86—Hydrazides; Thio or imino analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD84266047A 1983-08-09 1984-08-07 Verfahren zur herstellung neuer acylierter hydrazinverbindungen DD223447A5 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH433383 1983-08-09
CH493183 1983-09-09
CH112184 1984-03-07
CH116984 1984-03-09

Publications (1)

Publication Number Publication Date
DD223447A5 true DD223447A5 (de) 1985-06-12

Family

ID=27428091

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84266047A DD223447A5 (de) 1983-08-09 1984-08-07 Verfahren zur herstellung neuer acylierter hydrazinverbindungen

Country Status (11)

Country Link
EP (1) EP0139917A1 (el)
AU (1) AU3173384A (el)
DD (1) DD223447A5 (el)
DK (1) DK381784A (el)
ES (1) ES534940A1 (el)
FI (1) FI843086A (el)
GR (1) GR80055B (el)
HU (1) HUT34733A (el)
IL (1) IL72596A0 (el)
NO (1) NO843171L (el)
PT (1) PT79024A (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657610A1 (fr) * 1990-01-29 1991-08-02 Rhone Poulenc Agrochimie Triazolopyridines herbicides.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071632A (en) * 1976-12-30 1978-01-31 Morton-Norwich Products, Inc. Method of alleviating hypertension
US4260767A (en) * 1979-12-26 1981-04-07 American Cyanamid Company 2-Pyridylhydrazides

Also Published As

Publication number Publication date
DK381784D0 (da) 1984-08-08
FI843086A (fi) 1985-02-10
NO843171L (no) 1985-02-11
IL72596A0 (en) 1984-11-30
EP0139917A1 (de) 1985-05-08
ES534940A1 (es) 1985-11-01
FI843086A0 (fi) 1984-08-06
GR80055B (en) 1984-12-12
PT79024A (en) 1984-09-01
HUT34733A (en) 1985-04-28
AU3173384A (en) 1985-02-14
DK381784A (da) 1985-02-10

Similar Documents

Publication Publication Date Title
DE60317466T2 (de) Nicotinamidderivate, die als PDE4--Inhibitoren einsetzbar sind
EP0771197B1 (de) Verwendung heterocyclischer verbindungen als dopamin-d 3 liganden
EP0527736B1 (de) Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
EP0012361B1 (de) Amino-pyrimidin-carbanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel
EP0772603A1 (de) Substituierte pyrimidinverbindungen und deren verwendung
DE2520910A1 (de) Cyclisch substituierte derivate des 1-amino-2-propanol
DE3347565A1 (de) Neue phenylessigsaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CH641772A5 (de) Cyanoguanidin-derivate und verfahren zu ihrer herstellung.
EP0490820A2 (de) Biphenylyl-Verbindungen
DE1695897A1 (de) N-Acyl-sydnonimin-Derivate
WO1993004035A1 (de) Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel
DE4243858A1 (de) Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE69222459T2 (de) Thiazolidindionderivate, ihre Herstellung und Anwendung
DE2701794A1 (de) Oxigenierte n-aryl-diazacyclen
DE60012288T2 (de) Antivirale pyrimidindion-derivate und verfahren zu ihrer herstellung
CH504416A (de) Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
EP0557879B1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE69908371T2 (de) Thioethergruppen enthaltende distamycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
EP0093252B1 (de) Thiomethylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD146953A5 (de) Verfahren zur herstellung von pyrimidonderivaten
DE69922378T2 (de) Oxidierte sulfurierte distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
DE3215676C2 (de) Amidinderivate, Verfahren zu deren Herstellung und pharmazeutische Mittel, die diese Verbindungen enthalten
DE2804518C2 (de) 5-[3,6-Dihydro-1(2H)-Pyridyl]-2 oxo-2H-[1,2,4]-oxadiazolo-[2,3-a]-pyrimidin-7-carbamate
DD223447A5 (de) Verfahren zur herstellung neuer acylierter hydrazinverbindungen
EP2029580B1 (de) Neue indol-pyrrol-derivate zur behandlung proliferativer und inflammatorischer krankheiten